SCHEMBL29999937

SCHEMBL29999937

CCOC(=O)c1[nH]c2c(Br)c(F)ccc2c1CCCOc1cccc2cc(F)ccc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCL1 Q07820 18/20 0.47
BCL2 P10415 2/20 0.44
BCL2L1 Q07817 1/20 0.44
ALB P02768 1/20 0.43
PRKCD Q05655 2/20 0.41
CAMK2B Q13554 2/20 0.41
CAMK2G Q13555 2/20 0.41
EEF2K O00418 1/20 0.41
MARK3 P27448 1/20 0.41
AXL P30530 1/20 0.41
BCL6 P41182 1/20 0.41
NEK4 P51957 1/20 0.41
PRKAA1 Q13131 1/20 0.41
CAMK2D Q13557 1/20 0.41
MARK2 Q7KZI7 1/20 0.41
PIM3 Q86V86 1/20 0.41
HIPK2 Q9H2X6 1/20 0.41
MKNK2 Q9HBH9 1/20 0.41
MAP3K20 Q9NYL2 1/20 0.41
MAP4K5 Q9Y4K4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22436687 1.00 MCL1 (0.47) MCL1BCL2BCL2L1ALBPRKCD
SCHEMBL30000817 0.93 MCL1 (0.55) MCL1BCL2BCL2L1ALBPRKCD
SCHEMBL22436730 0.93 MCL1 (0.55) MCL1BCL2BCL2L1ALBPRKCD
SCHEMBL22436674 0.91 MCL1 (0.46) MCL1BCL2BCL2L1ALBPRKCD
SCHEMBL29470900 0.91 MCL1 (0.46) MCL1BCL2BCL2L1ALBPRKCD
SCHEMBL24745362 0.90 MCL1 (0.46) MCL1BCL2BCL2L1ALBPRKCD
SCHEMBL30000122 0.90 MCL1 (0.46) MCL1BCL2BCL2L1ALBPRKCD
SCHEMBL24745269 0.89 MCL1 (0.58) MCL1BCL2BCL2L1ALBPRKCD
SCHEMBL22436672 0.83 MCL1 (0.42) MCL1BCL2BCL2L1ALBPRKCD
SCHEMBL19615272 0.83 MCL1 (0.60) MCL1BCL2BCL2L1ALBPRKCD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022255888-A1 TARGETED PROTEIN DEGRADATION USING BIFUNCTIONAL COMPOUNDS THAT BIND UBIQUITIN LIGASE AND TARGET MCL-1 PROTEIN CAPTOR THERAPEUTICS S.A. (PL) 2022-12-08 WO disclosed